Pipeline
| NAME | ORIGINATOR | INDICATION | DEVELOPMENT STATUS |
|---|---|---|---|
| Carbaglu® | Recordati | Organic acidemias (OA) | Filed in EU Phase III in U.S.A. |
| Normosang® | Recordati | Hepatic porphyria | Pre-registration in U.S.A |
| NX 1207 | Nymox | Benign prostatic hyperplasia (BPH) | Phase III |
| Lercanidipine/enalapril fixed combination* |
Recordati | Essential hypertension | Phase II |
| Cystadrops® | Recordati | Ocular cystinosis | Phase II |
| REC 0422 | Recordati | Overactive bladder and incontinence | Phase II |
| REC 1819 | Recordati | Overactive bladder and incontinence | Preclinical |
| REC 0438 | Recordati/UFPeptides | Overactive bladder in patients with spinal lesions | Preclinical |
